regeneron monoclonal antibodies treatment

Ads
related to: regeneron monoclonal antibodies treatment
Science to Medicine - Pushing The Bounds of Science

www.regeneron.com
Technology is foundational to our work inventing new medicines. Our technologies have accelerated and improved the discovery of antibody medicine.
About Regeneron
Genetic Research
Science & Technology
Antibodies at Work
See Approved Genmab Medicines - Connect with Medical Affairs

www.us.genmab.com
See How Genmab Remains Committed to Advancing Treatment Options. Sign Up for Updates. Genmab - Dedicated to Supporting Patients and the Medical Professionals who Care for Them.
Careers
Pipeline
Sign Up
About Us
Approved Medicines
Antibody Science

Search results

- Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
  Zacks via Yahoo Finance· 1 year ago
  Regeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
- Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
  Zacks via Yahoo Finance· 3 months ago
  Regeneron Pharmaceuticals, Inc. REGN suffered a setback as the FDA issued Complete Response Letters...
- Regeneron (REGN) Down 2.3% Since Last Earnings Report: Can It Rebound?
  Zacks via Yahoo Finance· 2 years ago
  A month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 2.3%...
- Regeneron (REGN) Q3 Earnings Coming Up: What's in the Cards?
  Zacks via Yahoo Finance· 2 years ago
  Regeneron Pharmaceuticals, Inc. REGN is scheduled to release third-quarter 2022 results on Nov 3,...
- Regeneron (REGN) Rare Disease Drug Gets FDA's Priority Review
  Zacks via Yahoo Finance· 1 year ago
  Regeneron Pharmaceuticals, Inc. REGN announced that the FDA has accepted for Priority Review the...
- Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
  Zacks via Yahoo Finance· 2 years ago
  Biotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
- Pipeline Moves: Phase III completion for Corcept’s relaorilant
  Clinical Trials Arena via Yahoo Finance· 1 month ago
  This week on Pipeline Moves, we kick off by looking at the completion of a Phase III trial by...
- If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
  Zacks via Yahoo Finance· 2 years ago
  For most investors, how much a stock's price changes over time is important. This factor can impact...
- WHO recommends use of two antibody drugs against Ebola
  Reuters via Yahoo News· 2 years ago
  The World Health Organization (WHO) on Friday recommended two monoclonal antibody treatments against...
- Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
  Zacks via Yahoo Finance· 2 years ago
  Regeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...